Nyxoah Stock Price To Sales
| NYXH Stock | USD 7.46 0.03 0.40% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Nyxoah's long-term financial health and intrinsic value.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Nyxoah Company Price To Sales Analysis
Nyxoah's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Nyxoah Price To Sales | 64.26 X |
Most of Nyxoah's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nyxoah is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Nyxoah has a Price To Sales of 64 times. This is 200.28% higher than that of the Health Care Equipment & Supplies sector and 154.7% higher than that of the Health Care industry. The price to sales for all United States stocks is notably lower than that of the firm.
Nyxoah Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nyxoah's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nyxoah could also be used in its relative valuation, which is a method of valuing Nyxoah by comparing valuation metrics of similar companies.Nyxoah is currently under evaluation in price to sales category among its peers.
Nyxoah Fundamentals
| Return On Equity | -0.77 | ||||
| Return On Asset | -0.34 | ||||
| Operating Margin | (19.40) % | ||||
| Current Valuation | 235.87 M | ||||
| Shares Outstanding | 37.44 M | ||||
| Shares Owned By Insiders | 41.73 % | ||||
| Shares Owned By Institutions | 25.39 % | ||||
| Number Of Shares Shorted | 123.16 K | ||||
| Price To Book | 2.56 X | ||||
| Price To Sales | 64.26 X | ||||
| Revenue | 4.52 M | ||||
| Gross Profit | 2.86 M | ||||
| EBITDA | (58.05 M) | ||||
| Net Income | (56.43 M) | ||||
| Cash And Equivalents | 123.32 M | ||||
| Cash Per Share | 4.77 X | ||||
| Total Debt | 22.65 M | ||||
| Debt To Equity | 0.09 % | ||||
| Current Ratio | 7.24 X | ||||
| Book Value Per Share | 2.48 X | ||||
| Cash Flow From Operations | (49.23 M) | ||||
| Short Ratio | 3.30 X | ||||
| Earnings Per Share | (2.35) X | ||||
| Target Price | 12.85 | ||||
| Number Of Employees | 183 | ||||
| Beta | 0.65 | ||||
| Market Capitalization | 280.43 M | ||||
| Total Asset | 158.41 M | ||||
| Retained Earnings | (217.74 M) | ||||
| Working Capital | 76.55 M | ||||
| Net Asset | 158.41 M |
About Nyxoah Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nyxoah's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nyxoah using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nyxoah based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Nyxoah offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nyxoah's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nyxoah Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nyxoah Stock:Check out Nyxoah Piotroski F Score and Nyxoah Altman Z Score analysis. For more detail on how to invest in Nyxoah Stock please use our How to Invest in Nyxoah guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nyxoah. If investors know Nyxoah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nyxoah listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Nyxoah is measured differently than its book value, which is the value of Nyxoah that is recorded on the company's balance sheet. Investors also form their own opinion of Nyxoah's value that differs from its market value or its book value, called intrinsic value, which is Nyxoah's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nyxoah's market value can be influenced by many factors that don't directly affect Nyxoah's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nyxoah's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nyxoah is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nyxoah's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.